Csafe and biolife solutions, inc. announce partnership to expand supply chain solutions for the cell and gene therapy market

Csafe joins biolife's global partner network of cold chain solution providers using the evo® cold chain management platform monroe, ohio and bothell, wash. , oct. 11, 2022 /prnewswire/ -- csafe, one of the largest active and passive temperature-controlled shipping solutions providers for pharmaceuticals, and biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy ("cgt") and broader biopharma markets, announced today a new partnership to provide a combined global service network to support cgt products, with a focus on enhanced reliability, security and quality.
BLFS Ratings Summary
BLFS Quant Ranking